Development of Clinical Dosage Forms for a Poorly Water Soluble Drug I: Application of Polyethylene Glycol-Polysorbate 80 Solid Dispersion Carrier System

Journal of Pharmaceutical Sciences

Volumn 93, Issue 5, 2004, Pages 1165-1175

  Dannenfelser, Rose Marie ^a   He, Handan ^a   Joshi, Yatindra ^a   Bateman, Simon ^a   Serajuddin, Abu T M ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Bioavailability enhancement; PEG; Poorly soluble; Solid dispersion

Indexed keywords

DRUG; LAB 687; MACROGOL; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; NONHUMAN;

EID: 1942434691     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20044     Document Type: Article

References (27)

1. Martin A. 1993. Physical pharmacy. Pennsylvania: Lea & Febiger. p 213.
2. Horter D, Dressman JB. 1997. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Del Rev 25:3-14.
3. Serajuddin ATM. 1999. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88:1058-1066.
4. Kushida I, Ichikawa M, Asakawa N. 2002. Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion. J Pharm Sci 91:258-266.
5. Chiou WL, Riegelman S. 1971. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281-1302.
6. Shah JS, Chen JR, Chow D. 1995. Preformulation study of etoposide: Enhanced solubility and dissolution rate by solid-dispersions. Int J Pharm 113: 103-111.
7. Okimoto K, Miyake M, Ibiki R, Yasumura M, Ohnishi N, Nakai T. 1997. Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose. Int J Pharm 159:85-93.
8. Perng CY, Kearney AS, Patel K, Palepu NR, Zuber G. 1998. Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor. Int J Pharm 176:31-38.
9. Shah N, Pytelewski R, Eisen H, Jarowski CI. 1974. Influence of dispersion method on dissolution rate and bioavailability of digoxin from triturations and compressed tablets. II. J Pharm Sci 63:339-344.
10. Danjo K, Nakata T, Otsuka A. 1997. Preparation and dissolution of ethenzamide solid dispersions using various sugars as dispersion carrier. Chem Pharm Bull 45:1840-1844.
11. Sugimoto I, Sasaka K, Kuchiki A, Ishihara T, Nakagawa H. 1982. Stability and bioavailability of nifedipine in fine granules. Chem Pharm Bull 30:4479-4488.
12. Suzuki H, Sunada H. 1998. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem Pharm Bull 46:482-487.
13. Save T, Venkitachalam P. 1992. Studies on solid dispersions of nifedipine. Drug Dev Ind Pharm 18:1663-1679.
14. Akbuga J, Gursoy A, Kendi E. 1988. The preparation and stability of fast release furosemide-PVP solid dispersion. Drug Dev Ind Pharm 14:1439-1464.
15. Shin SC, Oh IJ, Lee YB, Choi HK, Choi JS. 1998. Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone. Ind J Pharm 175:217-224.
16. Ford JL. 1986. The current status of solid dispersions. Pharm Acta Helv 61:69-88.
17. Serajuddin ATM, Sheen PC, Mufson D, Bernstein DF, Augustine MA. 1988. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J Pharm Sci 77:414-417.
18. Serajuddin ATM, Sheen PC, Augustine MA. 1990. Improved dissolution of a poorly water-soluble drug from solid dispersions in polyethylene glycol:polysorbate 80 mixtures. J Pharm Sci 79:463-464.
19. Serajuddin ATM, Thakur AB, Ghoshal RN, Fakes MG, Ranadive SA, Morris KR, Varia SA. 1999. Selection of solid dosage form composition through drug-excipient compatibility testing. J Pharm Sci 88:696-704.
20. Morris KR, Knipp GT, Serajuddin ATM. 1992. Structural properties of polyethylene glycol-polysorbate 80 mixture, a solid dispersion vehicle. J Pharm Sci 81:1185-1188.
21. Joshi HN, Tejwani RW, Davidovich M, Sahasrabudhe VP, Jemal M, Bathala MS, Varia SA, Serajuddin ATM. 2004. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int J Pharm 269:251-258.
22. Tejwani RW, Joshi HN, Varia SA, Serajuddin ATM. 2000. Study of phase behavior of poly(ethylene glycol)-polysorbate 80 and poly(ethylene glycol)-polysorbate 80-water mixtures. J Pharm Sci 89: 946-950.
23. Serajuddin ATM, Sheen PC, Mufson D, Bernstein DF, Augustine MA. 1988. Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions. J Pharm Sci 77:325-329.
24. Chafetz L, Hong W, Tsilifonis DC, Taylor AK, Philip J. 1984. Decrease in the rate of capsule dissolution due to formaldehyde from polysorbate 80 autooxidation. J Pharm Sci 73:1186-1187.
25. Dressman JB, Reppas C. 2000. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci 11(Suppl 2):S35-S80.
26. Chiou WL, Buehler PW. 2002. Comparison of oral absorption and bioavailability of drugs between monkeys and human. Pharm Res 19:868-874.
27. Dannenfelser R. Personal communication.